Vaxcyte (PCVX): Prices about $1B stock and convertible raise to fund VAX-31
Vaxcyte priced about $1B of funding: 7.4M shares at $64 plus pre-funded warrants, and $500M of 1.5% convertible notes due 2032. Proceeds back VAX-31…
Vaxcyte (PCVX)
2 takes
All Centiview takes on Vaxcyte (ticker PCVX): earnings, deals and market news, newest first. Filed under Healthcare; region: US. Each take lists its sources. For information only, not advice.
Vaxcyte Shares Soar on Positive Phase 3 Vaccine Data ($PCVX)
Vaxcyte's pneumonia vaccine VAX-31 just hit all its goals in a major trial, matching or beating today's top shots from Pfizer and Merck. Shares…